Acquired hemophilia A: Clinical features, surgery and treatment of 34 cases, and experience of using recombinant factor VIIa

Clinical and Applied Thrombosis/Hemostasis

Volumn 16, Issue 3, 2010, Pages 294-300

  Lak, Manijeh ^a   Sharifian, Ramezan Ali ^a   Karimi, Katayon ^a   Mansouritorghabeh, Hassan ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acquired hemophilia A; Factor VIII inhibitor; Hemorrhage; Inhibitor elimination; Surgery management

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; AUTOANTIBODY; BLOOD CLOTTING FACTOR 8; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISOLONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; STEROID; TRANEXAMIC ACID;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBODY TITER; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARTMENT SYNDROME; ECCHYMOSIS; FEMALE; HEMARTHROSIS; HEMATOMA; HEMATURIA; HEMOPHILIA A; HUMAN; MALE; MENORRHAGIA; PRIORITY JOURNAL; RARE DISEASE; REMISSION; SINGLE DRUG DOSE; SYMPTOM; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; BLOOD LOSS, SURGICAL; COMPARTMENT SYNDROMES; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FACTOR VIIA; FACTOR VIII; FEMALE; HEMOPHILIA A; HEMORRHAGE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; IRAN; MALE; MIDDLE AGED; NEOPLASMS; POSTPARTUM HEMORRHAGE; PREDNISOLONE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77953631384     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029608331227     Document Type: Article

References (20)

1. Lottenberg R., Kentro TB, Kitchens CS Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Intern Med. 1987 ; 147: 1077-1081.
2. Sumner MJ, Geldziler BD, Pedersen M., Seremetis S. Treatment of acquired hemophilia with recombinant activated FVII: a critical appraisal. Haemophilia. 2007 ; 13: 451-461.
3. Green D., Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost. 1981 ; 45: 200-203.
4. Lusher JM Acquired inhibitors to factor VIII in non-hemophilic patients. In: Kessler C, Garvey MB, Green D, et al, eds. Acquired Hemophilia. Princeton, NJ: Excerpta Medica Inc ; 1995: 1-6.
5. Scandella DH, Nakai H., Felch M., et al. In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic. Thromb Res. 2001 ; 101: 377-385.
6. Gill JC Acquired hemophilia A: is more better. Blood. 2007 ; 109: 1793-1794.
7. Lambotte O., Dautremer J., Guillet B., et al. Acquired hemophilia in older people: a poor prognosis despite intensive care. J Am Geriatr Soc. 2007 ; 55: 1682-1685.
8. Michiels JJ Acquired hemophilia in woman post partum: clinical manifestations, diagnosis, and treatment. Clin Appl Thromb Hemost. 2000 ; 6: 82-86.
9. Bossi P., Cabane J., Ninet J., et al. Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med. 1998 ; 105: 400-408.
10. Macik BG Treatment of factor VIII inhibitors: products and strategies. Semin Thromb Haemost. 1003 ; 19: 13-24.
11. Holme PA, Brosstad F., Tjønnfjord GE Acquired hemophilia: management of bleeds and immune therapy to eradicate autoantibodies. Haemophilia. 2005 ; 11: 510-515.
12. Franchini M., Gandini G., Di Paolantonio T., Mariani G. Acquired hemophilia A: a concise review. Am J Hematol. 2005 ; 80: 55-63.
13. Franchini M., Capra F., Nicolini N., et al. Druginducedanti-factor VIII antibodies: a systematic review. Med Sci Monit. 2007 ; 13: RA55 - RA61.
14. Cohen AJ, Kessler CM Acquired inhibitors. Bailleres Clin Haematol. 1996 ; 9: 331-354.
15. Solymoss S. Postpartum acquired factor VIII inhibitors: result of a survey. Am J Haematol. 1998 ; 59: 1-4.
16. Kraut EH, Aledort LM, Arkin S., Stine KC, Wong WY Surgical interventions in a cohort of patients with hemophilia A and inhibitors: an experimental retrospective chart review. Haemophilia. 2007 ; 13: 508-517.
17. Hay CRM, Bolton-Maggs P. Porcine factor VIIIC in the management of patients with factor VIII inhibitors. Transfus Med Rev. 1991 ; 5: 145-151.
18. Negrier C., Goudemand J., Sultan Y., Bertrand M., Rothschild C., Lauroua P. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity. Thromb Haemost. 1997 ; 77: 1113-1119.
19. Collins PW, Hirsch S., Baglin TP, et al, UK Haemophilia Centre Doctors' Organisation. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood. 2007 ; 109: 1870-1877.
20. Kessel C., K̈nigs C., Linde R., et al. Humoral immune responsiveness to a defined epitope on factor VIII before and after B cell ablation with rituximab. Mol Immunol. 2008 ; 46: 8-15.